Incidence of diabetes mellitus complications as indicated by the register

1995 ◽  
Vol 41 (4) ◽  
pp. 8-11
Author(s):  
S. V. Kudryakova ◽  
Yu. I. Suntsov ◽  
S. G. Ryzhkova

The incidence of diabetes mellitus complications was assessed on the basis of diabetes mellitus register in 1478 diabetics living in the Lenin district of Moscow. The incidence of microangiopathies was reliably higher in patients with insulin-dependent condition (IDDM) than in those with the non-insulin dependent (NIDDM) one. The incidence of retinopathies and nephropathies was much higher in women with IDDM than in men. The incidence of macroangioptithies was higher in NIDDM than in those with IDDM. The incidence of coronary disease and arterial hypertension was the highest in women with NIDDM. The incidence of complications increased with a longer standing of the disease and age of the patients.


1994 ◽  
Vol 40 (1) ◽  
pp. 4-6
Author(s):  
S V Kudryakova ◽  
Yu I Suntsov

Data on lethal cases of diabetes mellitus which occurred before January 1, 1992 were recorded. The total number of diabetics in Leninsky district of Moscow was 1729, 86 of them with insulin-dependent and 1643 with noninsulindependent disease. Diabetes prevalence in the district was 2.4 %, that of insulin-dependent condition being 0.12 % and of noninsulin-dependent one 2.3 %. Various complications were detected in the majority of diabetics, microangiopathies (retinopathies, neuropathies) being the most incident in patients with insulin-dependent disease and macroangiopathies (coronary disease, arterial hypertension, myocardial infarction, brain stroke) predominating in patients with noninsulin-dependent disease. Cardiovascular diseases and involvement of the peripheral vessels were the most frequent causes of death of patients with both conditions.





1999 ◽  
Vol 45 (4) ◽  
pp. 15-18
Author(s):  
A. S. Ametov ◽  
E. V. Gubina

Althiazem РР is a selective blocker of slow calcium channels belonging to long-acting benzodiazepines, used for treating arterial hypertension. The efficacy and tolerance of 3-month monotherapy with althiazem PP in a daily dose of 180-360 mg was studied in 20 patients with non-insulin-dependent diabetes mellitus (NIDDM) combined with mild and moderate arterial hypertension. Acute drug test with daily arterial pressure (AP) monitoring showed that the number of the drug doses was determined by the severity of arterial hypertension and the circadian rhythm (r^0.68 and r—0.83, respectively). Daily monitoring of AP showed a significant decrease in the mean 24-h, mean daily, and mean nightly AP values. Diastolic AP normalized in 75%opatients and decreased by 10 mm Hg and more in 25%. "Pressure loading” in the daytime and at night decreased by 29.1 and 31.3%o, respectively. Increased variability of systolic AP for 24-h period decreased by 12.5%) during awakening hours and by 9.8% during sleeping. Heart rate virtually did not change. The drug exerted no negative effects on normal biphasic AP rhythm. Althiazem PP decreased the morning APpeak without notably changing the extent and rate of AP rises during the early morning hours. The drug had no negative effects on carbohydrate and lipid metabolism. Althiazem PP therapy had to be discontinued in only one female patient because of strong headaches. These data confirm high efficacy and good tolerance of althiazem PP as monotherapy for arterial hypertension in patients with NIDDM.





Sign in / Sign up

Export Citation Format

Share Document